R. David Peveler, Ph.D.
Senior Scientist

T: 202-266-5035
F: 202-557-3836
M: 201-913-0374
Download vCard

BS, Georgia Institute of Technology, Chemistry, 1969

Ph.D., Northwestern University, Organic Chemistry, 1975

Post-Doctoral Fellowship, University of Maine

MBA, Rutgers University, 1984



R. David Peveler, Ph.D. is a chemist with several areas of specialization. His areas of expertise include domestic and Canadian product regulatory compliance, Federal Food, Drug, and Cosmetic Act (FFDCA) Indirect Food Additive and packaging matters, Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) product registration and labeling matters, Department of Transportation (DOT) classification and labeling issues, and product safety (Occupational Safety and Health Administration (OSHA)/Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and Workplace Hazardous Materials Information System (WHMIS) compliant Material Safety Data Sheets (MSDS) and labels). He is an authority in the Premanufacture Notification (PMN) review process and guides clients in preparation of PMNs, including any needed interaction with the U.S. Environmental Protection Agency (EPA) in support of the PMN after submission. Dr. Peveler also provides preparation and submission of New Substance Notifications in Canada.

Dr. Peveler is very familiar with the Systems, Applications and Products (SAP) enterprise resource planning software for the environmental, health and safety (EHS) module and the role it plays in support of regulatory compliance. He is extraordinarily adept at putting EPA’s eTSCA/e-PMN software to good use for The Acta Group (Acta®) clients.

Previous to joining Acta, Dr. Peveler served as a consultant to Evonik Degussa Corporation and managed a variety of product regulatory compliance matters under Toxic Substances Control Act (TSCA), FFDCA, and related chemical product laws and regulatory programs. His work there provided special emphasis on U.S. Food and Drug Administration (FDA) regulations around bulk active pharmaceutical ingredients (API), including drug master files, drug establishment registrations, drug product listings, labeling, and import requirements. He also worked on the implementation of expert rules for use with Evonik’s product safety software, SAP EH&S.

Prior to Evonik Degussa, Dr. Peveler was a Senior Regulatory Scientist with Chemtura Corporation, where he managed TSCA and Canadian Domestic Substance List (DSL) issues and chemistries, ranging from mineral oils to complex reaction products, a wide variety of FFDCA direct and indirect food contact matters, and DOT classification and training issues. Before Chemtura, Dr. Peveler was at Witco Corporation, as Manager of Regulatory Affairs for the Polymer Additives Group. He also served as R&D Group Leader, where he directed researchers in a variety of areas involving polymer additives, including PVC heat stabilizers and polymeric plasticizers, and antioxidants for polyolefins.

Representative Engagements:

  • Submitted a PMN for a key component of a system for the detection of chemical weapons and overcame various issues that EPA had with the PMN substance.
  • Presented on global implementation of the GHS at a corporate meeting of regulatory affairs managers, which was well-received.
  • Submitted a Significant New Activities Notice (SNAN) in Canada for carbon nanotubes.
  • Prepared and submitted over a dozen e-PMNs for assorted clients.


Lynn L. Bergeson, Charles M. Auer, and R. David Peveler, "TSCA and the Regulation of Renewable Chemicals," American Oil Chemists’ Society INFORM, July/August, 2013.

Lynn L. Bergeson, Charles M. Auer, and R. David Peveler, "TSCA and the Regulation of Renewable Chemicals," Industrial Biotechnology, October 2012.

Beijing, China | Brussels, Belgium | Manchester, U.K. | Washington, D.C.
Contact • Twitter
Privacy Policy | Terms of Use | Cookie Policy
©2023 The Acta Group All Rights Reserved.